Clinical TrialsSearch results
Number of results: 395
Other
- AAA<aortic aneurismal remodeling by ARB> Study
- abdominal aortic aneurysm
- Cardiology, Nagoya University Graduate School of Meidicine
- 2009-07-16
Recruiting
- Prognostic study of risk stratification among Japanese patients with chronic kidney disease and ischemic heart disease using gated myocardial perfusion SPECT
- Chronic kidney disease, Ischemic heart disease
- Cardiovascular research foundation
- 2009-04-30
Other
- Double-blind Placebo-controlled Phase III Clinical Trial of TAP-144-SR (3M) in Patients with Spinal and Bulbar Muscular Atrophy (SBMA)
- Spinal and Bulbar Muscular Atrophy(SBMA)
- Center for Clinical Trials, Japan Medical Association
- 2006-09-05
Other
- Randomized controlled trial comparing ciprofloxacin and cefepime in febrile neutropenic patients with hematologic diseases (C-SHOT 0402 study)
- Febrile neutropenia
- Center for Supporting Hematology-Oncology Trials (C-SHOT)
- 2005-08-29
Other
- Phase II study of micafungin as empirical antifungal therapy for febrile neutropenic patients (C-SHOT 0503 study)
- Febrile neutropenia
- Center for Supporting Hematology-Oncology Trials (C-SHOT)
- 2006-03-30
Other
- Japan Morning Surge - Home Blood Pressure (J-HOP) study
- Subjects with any cardiovascular risk factors
- Center of Excellence (COE) Program / Division of Cardiovascular Medicine, Jichi Medical University
- 2007-11-15
Recruiting
- Phase 3 Study to Evaluate BIIB059 in Active SLE (TOPAZ-II Study)
- Systemic Lupus Erythematosus
- Cho Kyo
- 2021-11-01
Other
- A phase II/III clinical study of R442(Pegylated Interferon alfa-2a) for patients with chronic hepatitis B.
- chronic hepatitis B
- CHUGAI PHARMACEUTICAL CO.LTD.
- 2007-04-26
Other
- A phase II study of the combination of Rituximab, Mitoxantrone, Etoposide, and Prednisolone for relapsed elderly patients with diffuse large B-cell lymphoma (R-MEP07)
- Diffuse large B-cell lymphoma
- Clinical Hematology Study Group of National Hospital Organization (CHSG-NHO)
- 2008-03-01
Other
- A phase II study of the remission induction and maintenance therapy by rituximab for rituximab naive low grade B cell lymphoma.
- low grade B cell lymphoma
- Clinical Hematology Study Group of National Hospital Organization(CHSG-NHO)
- 2008-06-20